Low Testosterone (Male Hypogonadism) Protocol
Primary Stack
Core supplements with strongest evidenceVitamin D receptors present in testes; deficiency associated with low testosterone; supplementation may increase levels
Essential for testosterone synthesis; deficiency directly impairs testosterone production
Supporting Stack
Additional supplements for enhanced resultsAdaptogen that reduces cortisol, supports testicular function, and may increase testosterone and sperm quality
Supporting Studies (1)
May increase testosterone by reducing SHBG binding and supporting Leydig cell function
Supporting Studies (1)
Furostanolic saponins may inhibit enzymes that convert testosterone to estrogen and DHT
Supporting Studies (1)
Amino acid that may stimulate LH release and testosterone synthesis in the testes
Supporting Studies (1)
Involved in testosterone production; deficiency common in older men and associated with lower levels
Supporting Studies (1)
Trace mineral that may increase free testosterone by reducing SHBG levels
Supporting Studies (1)
How This Protocol Works
Simple Explanation
Testosterone is the primary male sex hormone, essential for muscle mass, bone density, energy, mood, libido, and overall vitality. Testosterone levels naturally decline about 1-2% per year after age 30. Low testosterone (hypogonadism) can cause fatigue, decreased libido, erectile dysfunction, loss of muscle mass, increased body fat, depression, and cognitive changes. While testosterone replacement therapy (TRT) is the most effective treatment for true hypogonadism, certain supplements may help optimize natural production.
IMPORTANT: Low testosterone should be diagnosed by blood tests (total and free testosterone, LH, FSH) and evaluated by a healthcare provider. These supplements are for optimization of natural production, not as replacements for TRT when medically indicated.
Expected timeline: Zinc/Vitamin D (if deficient): 4-8 weeks. Ashwagandha: 8-12 weeks. Tongkat Ali and Fenugreek: 4-8 weeks. Lifestyle factors (sleep, exercise, weight loss) are often more impactful than supplements.
Clinical Perspective
Male hypogonadism is defined biochemically as total testosterone <300 ng/dL (or <264 ng/dL per some guidelines) with symptoms. Primary hypogonadism involves testicular failure (elevated LH/FSH); secondary involves pituitary/hypothalamic dysfunction (low/normal LH/FSH). Causes include aging, obesity, diabetes, medications (opioids, glucocorticoids), chronic illness, and genetic conditions. TRT is standard treatment for confirmed hypogonadism. This protocol addresses lifestyle-modifiable factors and natural optimization.
CRITICAL: Confirm diagnosis with morning testosterone levels on two occasions. Evaluate for underlying causes. Supplements are for optimization, not treatment of clinical hypogonadism. TRT contraindicated with prostate cancer or erythrocytosis.
Biomarker targets: Total testosterone (morning), free testosterone, SHBG, LH, FSH, estradiol, PSA (before TRT), CBC (hematocrit), metabolic panel, vitamin D, zinc (plasma or RBC).
Protocol notes: Lifestyle interventions often more impactful than supplements: (1) Sleep optimization—testosterone produced during sleep; sleep apnea causes low T. (2) Resistance training—potent testosterone stimulus. (3) Weight loss—adipose tissue converts testosterone to estrogen (aromatase); 10% weight loss can increase testosterone 100 ng/dL. (4) Reduce alcohol—suppresses testosterone. (5) Stress management—cortisol inhibits testosterone. Rule out medication effects (opioids, glucocorticoids). Consider clomiphene citrate (off-label) for secondary hypogonadism if fertility desired. TRT options: injections, gels, pellets, patches—discuss with endocrinologist/urologist. Monitor hematocrit, PSA, lipids on TRT.